Literature DB >> 33980244

Correction to: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats.

Tewodros Mengesha1, Natesan Gnanasekaran2, Tsegaye Mehare3.   

Abstract

Entities:  

Year:  2021        PMID: 33980244      PMCID: PMC8114524          DOI: 10.1186/s12906-021-03313-2

Source DB:  PubMed          Journal:  BMC Complement Med Ther        ISSN: 2662-7671


× No keyword cloud information.
Correction to: BMC Complement Med Ther 21, 104 (2021) https://doi.org/10.1186/s12906-021-03275-5 Following publication of the original article [1], the authors reported an error in author name, affiliation, and in the Authors’ contributions statement. Authors’ contributions statement should read as below: Authors’ contributions This work was carried out in collaboration between all authors. TMR designed the study, performed the experiments, searched the literature, collected the data and wrote the manuscript. TM, review the data and give feedback on the article done. NG wrote the research protocol, provided the chemicals for the experiments and supervising the research work, structured the thesis and review the article. All authors read and approved the final manuscript. The original article [1] has been updated.
  1 in total

1.  Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats.

Authors:  Tewodros Mengesha; Natesan Gnanasekaran; Tsegaye Mehare
Journal:  BMC Complement Med Ther       Date:  2021-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.